When combined with the current results on the focal presence of LCN2 protein in the NASH liver, it is possible that, in the pathogenesis of NASH, liver LCN2 expression is increased in response to cytotoxic stresses having origins in inflammatory cells. The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatohepatitis.